Bank of America’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.2M Buy
637,690
+109,710
+21% +$3.99M ﹤0.01% 2095
2025
Q1
$19.1M Buy
527,980
+139,478
+36% +$5.05M ﹤0.01% 2152
2024
Q4
$16.3M Sell
388,502
-537,408
-58% -$22.6M ﹤0.01% 2122
2024
Q3
$51.4M Buy
925,910
+378,092
+69% +$21M ﹤0.01% 1351
2024
Q2
$22.5M Buy
547,818
+117,282
+27% +$4.82M ﹤0.01% 1859
2024
Q1
$20.1M Buy
430,536
+87,124
+25% +$4.07M ﹤0.01% 1976
2023
Q4
$16.4M Sell
343,412
-31,325
-8% -$1.5M ﹤0.01% 1980
2023
Q3
$13.4M Buy
374,737
+15,871
+4% +$566K ﹤0.01% 2072
2023
Q2
$16.6M Sell
358,866
-112,084
-24% -$5.17M ﹤0.01% 1887
2023
Q1
$18.9M Buy
470,950
+78,556
+20% +$3.15M ﹤0.01% 1885
2022
Q4
$18.2M Buy
392,394
+25,198
+7% +$1.17M ﹤0.01% 1798
2022
Q3
$15.2M Sell
367,196
-46,535
-11% -$1.93M ﹤0.01% 1865
2022
Q2
$24.7M Buy
413,731
+78,248
+23% +$4.67M ﹤0.01% 1592
2022
Q1
$24.4M Buy
335,483
+88,687
+36% +$6.44M ﹤0.01% 1731
2021
Q4
$20.8M Sell
246,796
-18,077
-7% -$1.52M ﹤0.01% 1871
2021
Q3
$23.9M Buy
264,873
+28,365
+12% +$2.56M ﹤0.01% 1754
2021
Q2
$22.6M Sell
236,508
-42,793
-15% -$4.08M ﹤0.01% 1792
2021
Q1
$31.8M Sell
279,301
-9,012
-3% -$1.03M ﹤0.01% 1481
2020
Q4
$39.9M Buy
288,313
+18,795
+7% +$2.6M 0.01% 1177
2020
Q3
$22.2M Buy
269,518
+67,613
+33% +$5.56M ﹤0.01% 1439
2020
Q2
$15.8M Sell
201,905
-39,107
-16% -$3.06M ﹤0.01% 1634
2020
Q1
$10.7M Buy
241,012
+86,631
+56% +$3.85M ﹤0.01% 1784
2019
Q4
$6.59M Buy
154,381
+15,559
+11% +$665K ﹤0.01% 2548
2019
Q3
$5.94M Sell
138,822
-21,545
-13% -$922K ﹤0.01% 2589
2019
Q2
$10.2M Buy
160,367
+30,903
+24% +$1.96M ﹤0.01% 2173
2019
Q1
$8.98M Buy
129,464
+68,520
+112% +$4.75M ﹤0.01% 2240
2018
Q4
$2.65M Buy
60,944
+10,365
+20% +$451K ﹤0.01% 3108
2018
Q3
$3.86M Sell
50,579
-15,212
-23% -$1.16M ﹤0.01% 2973
2018
Q2
$5.06M Buy
65,791
+25,219
+62% +$1.94M ﹤0.01% 2713
2018
Q1
$2.07M Buy
40,572
+6,967
+21% +$355K ﹤0.01% 3342
2017
Q4
$1.56M Sell
33,605
-36,168
-52% -$1.68M ﹤0.01% 3546
2017
Q3
$3.72M Buy
69,773
+25,749
+58% +$1.37M ﹤0.01% 2965
2017
Q2
$2.73M Sell
44,024
-4,853
-10% -$301K ﹤0.01% 3100
2017
Q1
$3.31M Buy
48,877
+4,417
+10% +$299K ﹤0.01% 2928
2016
Q4
$3.13M Buy
44,460
+4,377
+11% +$308K ﹤0.01% 2872
2016
Q3
$2.84M Buy
40,083
+3,128
+8% +$222K ﹤0.01% 2838
2016
Q2
$1.81M Buy
36,955
+7,894
+27% +$386K ﹤0.01% 3124
2016
Q1
$1.84M Sell
29,061
-16,499
-36% -$1.05M ﹤0.01% 3036
2015
Q4
$5.11M Sell
45,560
-776
-2% -$87.1K ﹤0.01% 2376
2015
Q3
$4.46M Buy
46,336
+37,170
+406% +$3.58M ﹤0.01% 2457
2015
Q2
$939K Buy
9,166
+8,385
+1,074% +$859K ﹤0.01% 3344
2015
Q1
$48K Sell
781
-2,046
-72% -$126K ﹤0.01% 4700
2014
Q4
$124K Buy
2,827
+2,150
+318% +$94.3K ﹤0.01% 4430
2014
Q3
$38K Sell
677
-8,139
-92% -$457K ﹤0.01% 4988
2014
Q2
$396K Buy
8,816
+8,216
+1,369% +$369K ﹤0.01% 3692
2014
Q1
$29K Buy
+600
New +$29K ﹤0.01% 4984